Toby Eyre, CLL specialist at Oxford University Hospitals, shared on X:
“Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study – The Lancet Haematology.”
Read further.
Source: Toby Eyre/X